There are multiple clinical trials underway for individuals with liver cancer. For a more comprehensive list of sorafenib clinical trials, please visit clinicaltrials.gov or call 866-639-2827.
Study Design: Randomized, double-blind, placebo-controlled study
Patients: Patients with HCC treatment following surgery or local treatment
Purpose: To compare the efficacy of sorafenib as an adjuvant treatment by assessing recurrence free survival, as well as differences in time to recurrence and overall survival
Location: North America, South America, Europe, and the Asia-Pacific region